메뉴 건너뛰기




Volumn 37, Issue 2, 2003, Pages 237-246

Desloratadine: A nonsedating antihistamine

Author keywords

Allergic rhinitis; Desloratadine; Urticaria

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; CETIRIZINE; DESLORATADINE; FEXOFENADINE; LORATADINE; TERFENADINE;

EID: 0037314793     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002800303700216     Document Type: Article
Times cited : (22)

References (88)
  • 2
    • 0032919046 scopus 로고    scopus 로고
    • Second-generation antihistamines: A comparative review
    • Slater JW, Zechnich AD, Haxby DG. Second-generation antihistamines: a comparative review. Drugs 1999;57:31-47.
    • (1999) Drugs , vol.57 , pp. 31-47
    • Slater, J.W.1    Zechnich, A.D.2    Haxby, D.G.3
  • 5
    • 0034105501 scopus 로고    scopus 로고
    • Evaluation of the cardiac safety of second-generation antihistamines
    • Taglialatela M, Annunziato L. Evaluation of the cardiac safety of second-generation antihistamines. Allergy 2000;55:22-30.
    • (2000) Allergy , vol.55 , pp. 22-30
    • Taglialatela, M.1    Annunziato, L.2
  • 6
    • 0032896891 scopus 로고    scopus 로고
    • Second-generation antihistamines: The risk of ventricular arrhythmias
    • DuBuske LM. Second-generation antihistamines: the risk of ventricular arrhythmias. Clin Ther 1999;21:281-95.
    • (1999) Clin Ther , vol.21 , pp. 281-295
    • DuBuske, L.M.1
  • 7
    • 0026427907 scopus 로고
    • Allergic rhinitis
    • Naclerio RM. Allergic rhinitis. N Engl J Med 1991;325:860-9.
    • (1991) N Engl J Med , vol.325 , pp. 860-869
    • Naclerio, R.M.1
  • 8
    • 0034912161 scopus 로고    scopus 로고
    • Allergic rhinitis: Definition, epidemiology, pathophysiology, detection, and diagnosis
    • Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 2001;108(suppl):S2-8.
    • (2001) J Allergy Clin Immunol , vol.108 , Issue.SUPPL.
    • Skoner, D.P.1
  • 9
    • 0034500798 scopus 로고    scopus 로고
    • Allergic rhinitis: Not purely a histamine-related disease
    • Howarth PH, Salagean M, Dokic D. Allergic rhinitis: not purely a histamine-related disease. Allergy 2000;55(suppl)64:7-16.
    • (2000) Allergy , vol.55 , Issue.64 SUPPL. , pp. 7-16
    • Howarth, P.H.1    Salagean, M.2    Dokic, D.3
  • 10
    • 0035137186 scopus 로고    scopus 로고
    • The pharmacologic profile of desloratadine: A review
    • Henz BM. The pharmacologic profile of desloratadine: a review. Allergy 2001;56(suppl 65):7-13.
    • (2001) Allergy , vol.56 , Issue.SUPPL. 65 , pp. 7-13
    • Henz, B.M.1
  • 16
    • 0030968998 scopus 로고    scopus 로고
    • Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells
    • Genovese A, Patella V, De Crescenzo G, De Paulis A, Spadaro G, Marone G. Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells. Clin Exp Allergy 1997:27:559-67.
    • (1997) Clin Exp Allergy , vol.27 , pp. 559-567
    • Genovese, A.1    Patella, V.2    De Crescenzo, G.3    De Paulis, A.4    Spadaro, G.5    Marone, G.6
  • 19
    • 0034845227 scopus 로고    scopus 로고
    • Inhibition of cytokine generation and mediator release in human basophils with desloratadine
    • Schroeder T, Schleimer RP, Lichtenstein LM, Kreutner W. Inhibition of cytokine generation and mediator release in human basophils with desloratadine. Clin Exp Allergy 2001;31:1369-77.
    • (2001) Clin Exp Allergy , vol.31 , pp. 1369-1377
    • Schroeder, T.1    Schleimer, R.P.2    Lichtenstein, L.M.3    Kreutner, W.4
  • 20
    • 0029010698 scopus 로고
    • Inhibitory activity of loratadine and descarboxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells
    • Vignola AM, Crampette L, Mondain M, Sauvere G, Czarlewski W, Bousquet J, et al. Inhibitory activity of loratadine and descarboxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells. Allergy 1995;50:200-3.
    • (1995) Allergy , vol.50 , pp. 200-203
    • Vignola, A.M.1    Crampette, L.2    Mondain, M.3    Sauvere, G.4    Czarlewski, W.5    Bousquet, J.6
  • 21
    • 0034908639 scopus 로고    scopus 로고
    • Effect of desloratadine and loratadine on rhinovirus-induced intercellular adhesion molecule I upregulation and promoter activation in respiratory epithelial cells
    • Papi A, Papadopoulos NG, Stanciu LA, Degitz K, Holgate ST, Johnston SL. Effect of desloratadine and loratadine on rhinovirus-induced intercellular adhesion molecule I upregulation and promoter activation in respiratory epithelial cells. J Allergy Clin Immunol 2001;108:221-8.
    • (2001) J Allergy Clin Immunol , vol.108 , pp. 221-228
    • Papi, A.1    Papadopoulos, N.G.2    Stanciu, L.A.3    Degitz, K.4    Holgate, S.T.5    Johnston, S.L.6
  • 22
    • 0030800848 scopus 로고    scopus 로고
    • Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-I expression
    • Ciprandi G, Pronzato C, Passalaqua G, Danzig M, Canonica GW. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-I expression. Clin Exp Allergy 1997;27:1175-83.
    • (1997) Clin Exp Allergy , vol.27 , pp. 1175-1183
    • Ciprandi, G.1    Pronzato, C.2    Passalaqua, G.3    Danzig, M.4    Canonica, G.W.5
  • 24
    • 0031920720 scopus 로고    scopus 로고
    • Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis
    • Abdelaziz H, Davakua JL, Khair OA, Bayram H, Prior AJ, Davies RJ. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1998;101:410-20.
    • (1998) J Allergy Clin Immunol , vol.101 , pp. 410-420
    • Abdelaziz, H.1    Davakua, J.L.2    Khair, O.A.3    Bayram, H.4    Prior, A.J.5    Davies, R.J.6
  • 25
    • 0026049747 scopus 로고
    • Suppressive effect of loratadine on allergen-induced histamine release in the nose
    • Andersson M, Nolte H, Baumgarten C, Pipkorn U. Suppressive effect of loratadine on allergen-induced histamine release in the nose. Allergy 1991;46:540-6.
    • (1991) Allergy , vol.46 , pp. 540-546
    • Andersson, M.1    Nolte, H.2    Baumgarten, C.3    Pipkorn, U.4
  • 27
    • 0029775852 scopus 로고    scopus 로고
    • Overview of allergic mechanisms. Ebastine has more than an antihistamine effect
    • Campbell A, Michel FB, Bremard-Oury C, Crampette L, Bousquet J. Overview of allergic mechanisms. Ebastine has more than an antihistamine effect. Drugs 1996;52(suppl 1):15-9.
    • (1996) Drugs , vol.52 , Issue.SUPPL. 1 , pp. 15-19
    • Campbell, A.1    Michel, F.B.2    Bremard-Oury, C.3    Crampette, L.4    Bousquet, J.5
  • 29
    • 0033032096 scopus 로고    scopus 로고
    • Histamine and tryptase in nasal lavage fluid after allergen challenge: Effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine
    • Jacobi HH, Skov PS, Poulsen LK, Malling HJ, Mygind N. Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine. J Allergy Clin Immunol 1999;103(5, pt 1):768-72.
    • (1999) J Allergy Clin Immunol , vol.103 , Issue.5 PART 1 , pp. 768-772
    • Jacobi, H.H.1    Skov, P.S.2    Poulsen, L.K.3    Malling, H.J.4    Mygind, N.5
  • 30
    • 9244253690 scopus 로고    scopus 로고
    • Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis
    • Bronsky EA, Dockhorn RJ, Meltzer EO, Shapiro G, Boltansky H, LaForce C, et al. Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:915-21.
    • (1996) J Allergy Clin Immunol , vol.97 , pp. 915-921
    • Bronsky, E.A.1    Dockhorn, R.J.2    Meltzer, E.O.3    Shapiro, G.4    Boltansky, H.5    LaForce, C.6
  • 31
    • 0025009223 scopus 로고
    • Allergen-induced increase in nonspecific nasal reactivity is blocked by antihistamines without a clearcut relationship to eosinophil influx
    • Klementsson H, Andersson M, Pipkorn U. Allergen-induced increase in nonspecific nasal reactivity is blocked by antihistamines without a clearcut relationship to eosinophil influx. J Allergy Clin Immunol 1990;86(4, pt 1):466-72.
    • (1990) J Allergy Clin Immunol , vol.86 , Issue.4 PART 1 , pp. 466-472
    • Klementsson, H.1    Andersson, M.2    Pipkorn, U.3
  • 32
    • 0029055475 scopus 로고
    • Effects of loratadine on anti-IgE-induced inflammation, histamine release, and leukocyte recruitment in skin of atopics
    • Roquet A, Raud J, Hallden G, van Hage-Hamsten M, Hed J, Hansson LO, et al. Effects of loratadine on anti-IgE-induced inflammation, histamine release, and leukocyte recruitment in skin of atopics. Allergy 1995;50:414-20.
    • (1995) Allergy , vol.50 , pp. 414-420
    • Roquet, A.1    Raud, J.2    Hallden, G.3    Van Hage-Hamsten, M.4    Hed, J.5    Hansson, L.O.6
  • 33
    • 0029116991 scopus 로고
    • Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy
    • Ciprandi G. Pronzato C, Ricca V, Varese P, Del Giacco GS, Canonica GW. Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy. Clin Exp Allergy 1995;25:871-8.
    • (1995) Clin Exp Allergy , vol.25 , pp. 871-878
    • Ciprandi, G.1    Pronzato, C.2    Ricca, V.3    Varese, P.4    Del Giacco, G.S.5    Canonica, G.W.6
  • 34
    • 0028897165 scopus 로고
    • Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and latephase reactions after allergen-specific challenge
    • Ciprandi G, Buscaglia S, Pesce G, Passalacqua G. Rihoux JP, Bagnasco M, et al. Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and latephase reactions after allergen-specific challenge. J Allergy Clin Immunol 1995;95:612-21.
    • (1995) J Allergy Clin Immunol , vol.95 , pp. 612-621
    • Ciprandi, G.1    Buscaglia, S.2    Pesce, G.3    Passalacqua, G.4    Rihoux, J.P.5    Bagnasco, M.6
  • 35
    • 85004775232 scopus 로고
    • Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo
    • Fadel R, Herpin-Richard N, Rihoux JP, Henocq E. Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo. Clin Allergy 1987;17:373-9.
    • (1987) Clin Allergy , vol.17 , pp. 373-379
    • Fadel, R.1    Herpin-Richard, N.2    Rihoux, J.P.3    Henocq, E.4
  • 36
    • 0029780284 scopus 로고    scopus 로고
    • A comparison of the effects of oral cetirizine and inhaled beclomethasone on early and late asthmatic responses to allergen and the associated increase in airways hyperresponsiveness
    • Bentley AM, Walker S, Hanotte F, De Vos C, Durham SR. A comparison of the effects of oral cetirizine and inhaled beclomethasone on early and late asthmatic responses to allergen and the associated increase in airways hyperresponsiveness. Clin Exp Allergy 1996;26:909-17.
    • (1996) Clin Exp Allergy , vol.26 , pp. 909-917
    • Bentley, A.M.1    Walker, S.2    Hanotte, F.3    De Vos, C.4    Durham, S.R.5
  • 38
    • 0034808214 scopus 로고    scopus 로고
    • Intranasal corticosteroids for allergic rhinitis: Superior relief?
    • Nielsen LP, Mygina N, Dahl R. Intranasal corticosteroids for allergic rhinitis: superior relief? Drugs 2001;61:1563-79.
    • (2001) Drugs , vol.61 , pp. 1563-1579
    • Nielsen, L.P.1    Mygina, N.2    Dahl, R.3
  • 39
    • 0034023585 scopus 로고    scopus 로고
    • The clinical relevance of the anti-inflammatory properties of antihistamines
    • Walsh GM. The clinical relevance of the anti-inflammatory properties of antihistamines. Allergy 2001;55:53-61.
    • (2001) Allergy , vol.55 , pp. 53-61
    • Walsh, G.M.1
  • 40
    • 0036117934 scopus 로고    scopus 로고
    • Rethinking our approach to allergic rhinitis management
    • Storms WW. Rethinking our approach to allergic rhinitis management. Ann Allergy Asthma Immunol 2002;88(suppl):30-5.
    • (2002) Ann Allergy Asthma Immunol , vol.88 , Issue.SUPPL. , pp. 30-35
    • Storms, W.W.1
  • 41
    • 0031946273 scopus 로고    scopus 로고
    • A review of the current guidelines for allergic rhinifis and asthma
    • Lemanske RF. A review of the current guidelines for allergic rhinifis and asthma. J Allergy Clin Immunol 1998;101(2, pt 2):S392-6.
    • (1998) J Allergy Clin Immunol , vol.101 , Issue.2 PART 2
    • Lemanske, R.F.1
  • 44
    • 0000625730 scopus 로고    scopus 로고
    • Doseproportionality, linearity, and pharmacokinetics of desloratadine in healthy adults
    • Herron JM, Padhi D, Affrime MB, Glue P, Gupta S, Banfield C. Doseproportionality, linearity, and pharmacokinetics of desloratadine in healthy adults (abstract). J Allergy Clin Immunol 2000;105(1, pt2):S385.
    • (2000) J Allergy Clin Immunol , vol.105 , Issue.1 PART 2
    • Herron, J.M.1    Padhi, D.2    Affrime, M.B.3    Glue, P.4    Gupta, S.5    Banfield, C.6
  • 45
    • 0000900182 scopus 로고    scopus 로고
    • Multiple-dose pharmacokinetics, safety, and tolerance of desloratadine in healthy volunteers
    • Padhi D, Banfield C, Gupta S, Glue P, Affrime MB. Multiple-dose pharmacokinetics, safety, and tolerance of desloratadine in healthy volunteers (abstract). J Allergy Clin Immunol 2000;105(1, pt 2):S385.
    • (2000) J Allergy Clin Immunol , vol.105 , Issue.1 PART 2
    • Padhi, D.1    Banfield, C.2    Gupta, S.3    Glue, P.4    Affrime, M.B.5
  • 46
    • 4244023430 scopus 로고    scopus 로고
    • Pharmacokinetic equivalence of pediatric dosages of desloratadine syrup in children and standard 5 mg desloratadine tablets in adults
    • Banfield C, Gupta S, Affrime M, Batra V. Pharmacokinetic equivalence of pediatric dosages of desloratadine syrup in children and standard 5 mg desloratadine tablets in adults (abstract). J Allergy Clin Immunol 2002;109(2, pt 2):S103.
    • (2002) J Allergy Clin Immunol , vol.109 , Issue.PART 2
    • Banfield, C.1    Gupta, S.2    Affrime, M.3    Batra, V.4
  • 47
    • 0034876431 scopus 로고    scopus 로고
    • In vitro characterization of the inhibition profile of loratadine, desloratadine, and 3-OHdesloratadine for five human cytochrome P450 enzymes
    • Barecki ME, Casciano CN, Johnson WW, Clement RP. In vitro characterization of the inhibition profile of loratadine, desloratadine, and 3-OHdesloratadine for five human cytochrome P450 enzymes. Drug Metab Dispos 2001;29:1173-5.
    • (2001) Drug Metab Dispos , vol.29 , pp. 1173-1175
    • Barecki, M.E.1    Casciano, C.N.2    Johnson, W.W.3    Clement, R.P.4
  • 48
  • 49
  • 50
    • 0035126404 scopus 로고    scopus 로고
    • 1-receptor antagonist, in patients with seasonal allergic rhinitis; assessment during the Spring and Fall allergy seasons
    • 1-receptor antagonist, in patients with seasonal allergic rhinitis; assessment during the Spring and Fall allergy seasons. Clin Drug Invest 2001;21:25-32.
    • (2001) Clin Drug Invest , vol.21 , pp. 25-32
    • Meltzer, E.O.1    Prenner, B.M.2    Nayak, A.3
  • 51
    • 0001075185 scopus 로고    scopus 로고
    • Efficacy and safety of desloratadine in seasonal allergic rhinitis
    • Salmun LM, Lober R, Danzig M, Staudinger H. Efficacy and safety of desloratadine in seasonal allergic rhinitis (abstract). J Allergy Clin Immunol 2000;105(1, pt 2):S384.
    • (2000) J Allergy Clin Immunol , vol.105 , Issue.1 PART 2
    • Salmun, L.M.1    Lober, R.2    Danzig, M.3    Staudinger, H.4
  • 52
    • 0036279872 scopus 로고    scopus 로고
    • Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit
    • Horak F, Stubner UP, Zieglmayer I, Ing D, Harris AG. Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. J Allergy Clin Immunol 2002;109:956-61.
    • (2002) J Allergy Clin Immunol , vol.109 , pp. 956-961
    • Horak, F.1    Stubner, U.P.2    Zieglmayer, I.3    Ing, D.4    Harris, A.G.5
  • 53
    • 0035131070 scopus 로고    scopus 로고
    • Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis
    • Bechert C. Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis. Allergy 2001;56:14-20.
    • (2001) Allergy , vol.56 , pp. 14-20
    • Bechert, C.1
  • 54
    • 0001075184 scopus 로고    scopus 로고
    • Decongestant effects of desloratadine in patients with seasonal allergic rhinitis
    • Nayak A, Lorbert R, Salman LM. Decongestant effects of desloratadine in patients with seasonal allergic rhinitis (abstract). J Allergy Clin Immunol 2000;105(1, pt 2):S384.
    • (2000) J Allergy Clin Immunol , vol.105 , Issue.1 PART 2
    • Nayak, A.1    Lorbert, R.2    Salman, L.M.3
  • 55
    • 0034748476 scopus 로고    scopus 로고
    • Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis
    • Nayak AS, Schenkel E. Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis. J Allergy Clin Immunol 2001;56:1077-80.
    • (2001) J Allergy Clin Immunol , vol.56 , pp. 1077-1080
    • Nayak, A.S.1    Schenkel, E.2
  • 56
    • 0001087070 scopus 로고    scopus 로고
    • Decongestant effects of desloratadine in patients with seasonal allergic rhinitis and asthma
    • Shapiro GG, the Desloratadine Study Group. Decongestant effects of desloratadine in patients with seasonal allergic rhinitis and asthma (abstract). J Allergy Clin Immunol 2001;107:S161.
    • (2001) J Allergy Clin Immunol , vol.107
    • Shapiro, G.G.1
  • 57
    • 0013062205 scopus 로고    scopus 로고
    • Fixed-dose desloratadine and pseudoepedrine relieves moderate/severe nasal congestion in patients with seasonal allergic rhinifis
    • Schenkel E, Corren J, Murray JJ. Fixed-dose desloratadine and pseudoepedrine relieves moderate/severe nasal congestion in patients with seasonal allergic rhinifis (abstract). J Allergy Clin Immunol 2002;109(2, pt 2):S103.
    • (2002) J Allergy Clin Immunol , vol.109 , Issue.2 PART 2
    • Schenkel, E.1    Corren, J.2    Murray, J.J.3
  • 58
    • 0001087071 scopus 로고    scopus 로고
    • Desloratadine reduces seasonal allergic rhinitis symptoms in patients with seasonal allergic rhinitis and asthma
    • Berger WE, the Desloratadine Study Group. Desloratadine reduces seasonal allergic rhinitis symptoms in patients with seasonal allergic rhinitis and asthma (abstract). J Allergy Clin Immunol 2001;107(2, pt 2):S162.
    • (2001) J Allergy Clin Immunol , vol.107 , Issue.2 PART 2
    • Berger, W.E.1
  • 59
    • 0001087069 scopus 로고    scopus 로고
    • Desloratadine reduces the use of inhaled beta 2-agonists and improves asthma symptoms in patients with seasonal allergic rhinitis and asthma
    • Corren J, the Desloratadine Study Group. Desloratadine reduces the use of inhaled beta 2-agonists and improves asthma symptoms in patients with seasonal allergic rhinitis and asthma (abstract). J Allergy Clin Immunol 2001;107(2, pt 2):S163.
    • (2001) J Allergy Clin Immunol , vol.107 , Issue.2 PART 2
    • Corren, J.1
  • 60
    • 85009032463 scopus 로고    scopus 로고
    • Desloratadine improved asthma symptoms and reduced bronchodilator use in 2 studies of patients with asthma and SAR
    • Ratner PH. the Desloratadine Study Group. Desloratadine improved asthma symptoms and reduced bronchodilator use in 2 studies of patients with asthma and SAR (abstract). Ann Allergy Asthma Immunol 2001;86:109:P63.
    • (2001) Ann Allergy Asthma Immunol , vol.86 , Issue.109
    • Ratner, P.H.1
  • 61
    • 0000336611 scopus 로고    scopus 로고
    • Once-daily desloratadine reduces the symptoms of perennial allergic rhinitis for at least 4 weeks
    • Dubuske LM, the Desloratadine Study Group. Once-daily desloratadine reduces the symptoms of perennial allergic rhinitis for at least 4 weeks (abstract). J Allergy Clin Immunol 2001;107(2, pt 2):S159.
    • (2001) J Allergy Clin Immunol , vol.107 , Issue.2 PART 2
    • Dubuske, L.M.1
  • 62
    • 80051499508 scopus 로고    scopus 로고
    • Kenilworth, NJ: Schering Corporation
    • Data on file. Kenilworth, NJ: Schering Corporation.
    • Data on File
  • 63
    • 0031469356 scopus 로고    scopus 로고
    • Allergic and immunologic skin disorders
    • Leung DY, Diaz LA, DeLeo V, Soter NA. Allergic and immunologic skin disorders. JAMA 1997;278:1914-23.
    • (1997) JAMA , vol.278 , pp. 1914-1923
    • Leung, D.Y.1    Diaz, L.A.2    DeLeo, V.3    Soter, N.A.4
  • 64
    • 0035092744 scopus 로고    scopus 로고
    • Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: A randomized, double-blind, placebo-controlled study
    • Ring J, Rudiger H, Gauger A, Bronsky E, Miller B. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Int J Dermatol 2001;40:1-5.
    • (2001) Int J Dermatol , vol.40 , pp. 1-5
    • Ring, J.1    Rudiger, H.2    Gauger, A.3    Bronsky, E.4    Miller, B.5
  • 66
    • 0034111253 scopus 로고    scopus 로고
    • 1 receptor antagonist. 2nd communication: Lack of central nervous system and cardiovascular effects
    • 1 receptor antagonist. 2nd communication: lack of central nervous system and cardiovascular effects. Arzneimittelforschung 2000;50:441-8.
    • (2000) Arzneimittelforschung , vol.50 , pp. 441-448
    • Kreutner, W.1    Hey, J.A.2    Chiu, P.3    Barnett, A.4
  • 68
    • 0001041493 scopus 로고    scopus 로고
    • Desloratadine has no effect on wakefulness or psychomotor performance
    • Scharf MB, Kay G, Rikken G. Desloratadine has no effect on wakefulness or psychomotor performance (abstract). Allergy 2000;55(suppl 63):280.
    • (2000) Allergy , vol.55 , Issue.SUPPL. 63 , pp. 280
    • Scharf, M.B.1    Kay, G.2    Rikken, G.3
  • 69
    • 0001061710 scopus 로고    scopus 로고
    • Desloratadine and alcohol coadministration: No increase in impairment of performance over that induced by alcohol alone
    • Rikken G, Scharf MB, Danzig MR. Desloratadine and alcohol coadministration: no increase in impairment of performance over that induced by alcohol alone (abstract). Allergy 2000;55(suppl 63):277.
    • (2000) Allergy , vol.55 , Issue.SUPPL. 63 , pp. 277
    • Rikken, G.1    Scharf, M.B.2    Danzig, M.R.3
  • 70
    • 0027118223 scopus 로고
    • From the US Food and Drug Administration. Warnings issued on nonsedating antihistamines terfenadine and astemizole
    • Nightingale SL. From the US Food and Drug Administration. Warnings issued on nonsedating antihistamines terfenadine and astemizole. JAMA 1992;268:705.
    • (1992) JAMA , vol.268 , pp. 705
    • Nightingale, S.L.1
  • 71
    • 0001352354 scopus 로고    scopus 로고
    • Desloratadine and erythromycin: Pharmacokinetics and electrocardiographic pharmacodynamic effects
    • Glue P, Banfield C, Affrime MB. Desloratadine and erythromycin: pharmacokinetics and electrocardiographic pharmacodynamic effects (abstract). J Allergy Clin Immunol 2000;105(1, pt 2):S387.
    • (2000) J Allergy Clin Immunol , vol.105 , Issue.1 PART 2
    • Glue, P.1    Banfield, C.2    Affrime, M.B.3
  • 73
    • 0036074083 scopus 로고    scopus 로고
    • Desloratadine has no clinically relevant electrocardiographic or pharmacodynamic interactions with ketoconazole
    • Banfield C, Herron J, Keung A, Padhi D, Affrime M. Desloratadine has no clinically relevant electrocardiographic or pharmacodynamic interactions with ketoconazole. Clin Pharmacokinet 2002;41(suppl 1):37-44.
    • (2002) Clin Pharmacokinet , vol.41 , Issue.SUPPL. 1 , pp. 37-44
    • Banfield, C.1    Herron, J.2    Keung, A.3    Padhi, D.4    Affrime, M.5
  • 74
    • 0003136113 scopus 로고    scopus 로고
    • No drug interaction between fluoxetine and desloratadine, a new nonsedating once-daily antihistamine
    • Banfield C, Gupta S, Kantesaria B. No drug interaction between fluoxetine and desloratadine, a new nonsedating once-daily antihistamine (abstract). J Allergy Clin Immunol 2001;107(2, pt 2):S529.
    • (2001) J Allergy Clin Immunol , vol.107 , Issue.2 PART 2
    • Banfield, C.1    Gupta, S.2    Kantesaria, B.3
  • 75
    • 0000259447 scopus 로고    scopus 로고
    • Effects of various cytochrome P450 inhibitors on the clearance of loratadine (L)/descarboethoxyloratadine (DCL) and lack of effects of increased L and DCL plasma concentrations on QTc intervals
    • Brannan M, Affrime M, Cayen M. Effects of various cytochrome P450 inhibitors on the clearance of loratadine (L)/descarboethoxyloratadine (DCL) and lack of effects of increased L and DCL plasma concentrations on QTc intervals (abstract). Allergy 1997;37(suppl 52):207.
    • (1997) Allergy , vol.37 , Issue.SUPPL. 52 , pp. 207
    • Brannan, M.1    Affrime, M.2    Cayen, M.3
  • 76
    • 0003218047 scopus 로고    scopus 로고
    • Unlike fexofenadine, the pharmacokinetics of desloratadine are minimally altered by coadministration with azithromycin
    • Gupta S, Banfield C, Lim J, Marino M, Clement RP, Affrime MB, et al. Unlike fexofenadine, the pharmacokinetics of desloratadine are minimally altered by coadministration with azithromycin (abstract). J Allergy Clin Immunol 2001;107(2, pt2):S159.
    • (2001) J Allergy Clin Immunol , vol.107 , Issue.2 PART 2
    • Gupta, S.1    Banfield, C.2    Lim, J.3    Marino, M.4    Clement, R.P.5    Affrime, M.B.6
  • 78
    • 0000924607 scopus 로고    scopus 로고
    • Effect of desloratadine on P-glycoprotein transport system (MDR1)
    • Cayen M, Wang E, Clement RP. Effect of desloratadine on P-glycoprotein transport system (MDR1) (abstract). Allergy 2000;(suppl 63):S282.
    • (2000) Allergy , Issue.SUPPL. 63
    • Cayen, M.1    Wang, E.2    Clement, R.P.3
  • 79
    • 0036091282 scopus 로고    scopus 로고
    • Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine
    • Banfield C, Samir G, Marino M. Lim J, Affrime M. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine. Clin Pharmacokinet 2002;41:311-8.
    • (2002) Clin Pharmacokinet , vol.41 , pp. 311-318
    • Banfield, C.1    Samir, G.2    Marino, M.3    Lim, J.4    Affrime, M.5
  • 82
    • 12244296941 scopus 로고    scopus 로고
    • Allergic rhinitis
    • Di Piro JT, Talbert RL, Yee GC, Matzke GR, Well BG, Posey LM, eds. Stanford, Connecticut:Appleton & Lange
    • May JR. Allergic Rhinitis. In: Di Piro JT, Talbert RL, Yee GC, Matzke GR, Well BG, Posey LM, eds. Pharmacotherapy: a pathophysiologic approach, Fourth Edition. Stanford, Connecticut:Appleton & Lange, 1999:1479-88.
    • (1999) Pharmacotherapy: A Pathophysiologic Approach, Fourth Edition , pp. 1479-1488
    • May, J.R.1
  • 83
    • 0036120561 scopus 로고    scopus 로고
    • The burden of allergic rhinitis: Beyond dollars and cents
    • Fineman SM. The burden of allergic rhinitis: beyond dollars and cents. Ann Allergy Asthma Immunol 2002;88(suppl):2-7.
    • (2002) Ann Allergy Asthma Immunol , vol.88 , Issue.SUPPL. , pp. 2-7
    • Fineman, S.M.1
  • 84
    • 0034912161 scopus 로고    scopus 로고
    • Allergic rhinitis: Definition, epidemiology, pathophysiology, detection, and diagnosis
    • Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 2001;108(suppl):S2-8.
    • (2001) J Allergy Clin Immunol , vol.108 , Issue.SUPPL.
    • Skoner, D.P.1
  • 85
    • 12244268453 scopus 로고    scopus 로고
    • Antihistamine OTC switch moves to legal arena after committee votes
    • Antihistamine OTC switch moves to legal arena after committee votes. FDC Reports, The Pink Sheet 2001;63(20):34.
    • (2001) FDC Reports, The Pink Sheet , vol.63 , Issue.20 , pp. 34
  • 86
    • 0034884337 scopus 로고    scopus 로고
    • Management of allergic rhinitis and sinusitis
    • Blake K, Larsen J. Management of allergic rhinitis and sinusitis. J Pharm Prac 2001;14:228-25.
    • (2001) J Pharm Prac , vol.14 , pp. 228-325
    • Blake, K.1    Larsen, J.2
  • 87
    • 12244275479 scopus 로고    scopus 로고
    • Schering-Plough Clarinex launch strategy follows Nexium model
    • Schering-Plough Clarinex launch strategy follows Nexium model. FDC Reports, The Pink Sheet 2002;64(1):9-10.
    • (2002) FDC Reports, The Pink Sheet , vol.64 , Issue.1 , pp. 9-10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.